Beijing Oriental Rada Biotech Co., Ltd.

natamycin 10% for feed

natamycin 10% for feed
Product Detailed

10%min natamycin
To treat most fungus and moulds infection
Widely used in feed
Kosher,Halal,ISO9001,ISO22000

Natamycin (Pimaricin) is an antimyotic product which has broad and effective power.It not only inhibits the growth of different moulds and yeasts.but also inhibits the production of their toxin growth. It is reliable in application and safe to human body. Natamycin has no effect on bacteria,so it does not prevent in the natural maturing process of food. It has been globally used in cheese, juice, fresh Ham,wine and meat industry. 

 

Registered Index: CAS[7681-93-8], INS235, EEC No.235

Molecular formular: C33H47NO13

Molecular weight:665.75

Quality Control:Kosher,Halal,ISO9001,ISO22000

 

PRODUCT SHEET

ITEMS

SPECIFICATIONS OF QUALITY

Appearance    

 White to yellow crystalline powder 

Content Natamycin

>10%

Moisture  

6.0-9.0%

pH   

5.0-7.5

Ash  

≤ 0.5%

Solution Color 

≤ 0.07  

Total plate counts   

Absent 

Total heavy metals(as Pb)

≤ 10 ppm

Pb

≤ 3 ppm

As

≤ 1 ppm

Hg

≤ 1 ppm

 

 

PRODUCT DESCRIPTION

ITEMS

FEATURES

Chemical characteristic

A polyene macrolide antibiotic production

Physical characteristic  

 White to yellow crystalline powder 

 Low solubility in water

Melting point 280°C(decomposed)

Stability

Extremely stable under dry condition

Suggested pH value: 4-7

Microbiologic Characteristic

effectively inhibit tmost mould and yeast

resultless in some microbes like lactic acid 

Toxicity

1. ADI 0~0.3mg/kg (FAO/WHO, 1994)

2. Safe to apply on food (FDA, §172.155, 1994)

3. LD50 2.73g/kg (experiment with matured male mouse) 

Quality Control

 

1.Kosher(OU), Halal,HACCP approved

2.ISO 9001, GMP certificataed

3.ISO 22000-2005

 

Used to

used as feed additive  for retarding the growth of Aspergillus parasiticus in broiler chicken feeds for up to 14 days after the addition of natamycin(21 C.F.R. § 573.685)



Copyright Notice @ 2008-2022 B2BAGE Limited and/or its subsidiaries and licensors. All rights reserved.